RYAN vs TMO · P/E 43, rev $2.46B vs P/E 24, rev $44.56B
Ryan Specialty Group Holdings Inc (RYAN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
RYAN currently screens at market cap $9.33B and trailing P/E 43.1. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the RYAN and TMO stock pages for the full models.
Not investment advice.